Novo Nordisk will cut prices of the diabetes and weight loss drugs Ozempic, Rybelsus and Wegovy to $675 effective Jan. 1, 2027.

Novo Nordisk is suing a Shrewsbury doctor who sells a cheaper compounded medicine version of its popular Ozempic and Wegovy ...

Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss ...

Novo Nordisk and Vivtex Corporation have entered into a partnership to develop next-generation oral biologic medicines for ...

Partnership will leverage Vivtex’s proprietary technologies built to identify optimal oral formulations for peptide and protein therapeutics with improved bioavailabilityNovo Nordisk will lead global ...

Novo Nordisk announced plans to drastically reduce the list price of its versions, Wegovy, Ozempic and Rybelsus.

Partnership will leverage Vivtex's proprietary technologies built to identify optimal oral formulations for peptide and protein therapeutics with improved bioavailabilityNovo Nordisk will lead global ...

Denmark’s Novo Nordisk has announced—effective January 1, 2027—a lower $675 US list price, or wholesale acquisition cost (WAC), for Wegovy (semaglutide) injection 2.4mg and tablets 25mg, Ozempic ...

Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug.

E very time you throw darts or ride a bike or even work out, you’re engaging your muscle memory. New research from the Norwegian School of Sport Sciences published in Science Advances shows our ...

International equities added another 5% in the fourth quarter, finishing up more than 30% for the year, the largest gain ...

The FDA has approved a label expansion for tirzepatide (Zepbound; Eli Lilly), allowing use of a 4-dose, single-patient-use KwikPen that delivers a full month of treatment in 1 device for chronic ...